LENSAR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.03 USD | -2.18% |
|
+5.22% | +14.81% |
| May. 09 | Transcript : LENSAR, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| May. 09 | Earnings Flash (LNSR) LENSAR Reports Q1 Revenue $10.6M | MT |
Presentation Operator MessageOperator (Operator)Good morning and thank you for your participat...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.
Calendar
2024-08-05
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.03
USD
Average target price
8
USD
Spread / Average Target
+98.51%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.81% | 45.92M | |
| +11.91% | 227B | |
| +15.46% | 198B | |
| +18.58% | 142B | |
| +30.36% | 111B | |
| +0.65% | 64.16B | |
| +17.74% | 54.1B | |
| +5.82% | 51.41B | |
| +11.23% | 45.32B | |
| +5.73% | 37.32B |
- Stock Market
- Equities
- LNSR Stock
- News LENSAR, Inc.
- Transcript : LENSAR, Inc., Q3 2021 Earnings Call, Nov 08, 2021